Defects in dosage compensation impact global gene regulation in the mouse trophoblast

Development. 2017 Aug 1;144(15):2784-2797. doi: 10.1242/dev.149138. Epub 2017 Jul 6.

Abstract

Xist RNA, which is responsible for X inactivation, is a key epigenetic player in the embryogenesis of female mammals. Of the several repeats conserved in Xist RNA, the A-repeat has been shown to be essential for its silencing function in differentiating embryonic stem cells. Here, we introduced a new Xist allele into mouse that produces mutated Xist RNA lacking the A-repeat (XistCAGΔ5' ). XistCAGΔ5' RNA expressed in the embryo coated the X chromosome but failed to silence it. Although imprinted X inactivation was substantially compromised upon paternal transmission, allele-specific RNA-seq in the trophoblast revealed that XistCAGΔ5' RNA still retained some silencing ability. Furthermore, the failure of imprinted X inactivation had more significant impacts than expected on genome-wide gene expression. It is likely that dosage compensation is required not only for equalizing X-linked gene expression between the sexes but also for proper global gene regulation in differentiated female somatic cells.

Keywords: Mouse; Transcriptome; Trophoblast; X chromosome inactivation; Xist RNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Animals
  • Cells, Cultured
  • Dosage Compensation, Genetic / genetics
  • Dosage Compensation, Genetic / physiology*
  • Embryonic Stem Cells / metabolism
  • Female
  • Fluorescent Antibody Technique
  • Gene Expression Regulation, Developmental / genetics*
  • Mice
  • Trophoblasts / metabolism*
  • X Chromosome / genetics
  • X Chromosome Inactivation / genetics